CSL Limited (CSLLY)
(Delayed Data from OTC)
$99.54 USD
+0.75 (0.76%)
Updated Oct 1, 2024 03:59 PM ET
4-Sell of 5 4
C Value B Growth D Momentum C VGM
CSL Limited Sponsored ADR (CSLLY) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$110.00 | $110.00 | $110.00 | 11.35% |
Price Target
Only one analyst offered a short-term price target of $110.00 for CSL Limited Sponsored ADR. This represents an increase of 11.35% from the last closing price of $98.79.
Analyst Price Targets (1 )
Broker Rating
CSL Limited Sponsored ADR currently has an average brokerage recommendation (ABR) of 1.57 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by seven brokerage firms. The current ABR compares to an ABR of 1.57 a month ago based on seven recommendations.
Of the seven recommendations deriving the current ABR, five are Strong Buy, representing 71.43% of all recommendations. A month ago, Strong Buy represented 71.43%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 5 | 5 | 5 | 5 | 5 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 2 | 2 | 2 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.57 | 1.57 | 1.57 | 1.57 | 1.57 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/14/2024 | Not Identified | Not Identified | Hold | Hold |
8/13/2024 | Macquarie Capital Securities | David Bailey | Not Available | Strong Buy |
2/20/2024 | UBS | Laura Sutcliffe | Strong Buy | Strong Buy |
2/14/2024 | Not Identified | Not Identified | Not Available | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.57 |
ABR (Last week) | 1.57 |
# of Recs in ABR | 7 |
Average Target Price | $110.00 |
LT Growth Rate | 14.70% |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 80 of 253 |
Current Quarter EPS Est: | NA |
CSLLY FAQs
CSL Limited Sponsored ADR (CSLLY) currently has an average brokerage recommendation (ABR) of 1.57 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 7 brokerage firms.
The average price target for CSL Limited Sponsored ADR (CSLLY) is $110.00. The current on short-term price targets is based on 3 reports.
The forecasts for CSL Limited Sponsored ADR (CSLLY) range from a low of $110 to a high of $110. The average price target represents a increase of $10.51 from the last closing price of $99.54.
The current UPSIDE for CSL Limited Sponsored ADR (CSLLY) is 10.51%
Only one analyst offered a short-term price target of $110.00 for CSL Limited Sponsored ADR. This represents an increase of 11.35% from the last closing price of $98.79.